K. Vermeire

E. Levtchenko, B. Sprangers, S. Hosgood, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Cellular electrical impedance to profile SARS-CoV-2 fusion inhibitors and to assess the fusogenic potential of spike mutants

D. Schols, S. Noppen, A. Stevaert, 2022, bioRxiv.

Proﬁle of Resistance of Human Immunodeﬁciency Virus to Mannose-Speciﬁc Plant Lectins

A. Vandamme, J. Balzarini, E. Clercq, 2004 .

Human Immunodeﬁciency Virus Type 1 Escape from Cyclotriazadisulfonamide-Induced CD4-Targeted Entry Inhibition Is Associated with Increased Neutralizing Antibody Susceptibility (cid:1)

D. Schols, K. Vermeire, T. Bell, 2009 .

Design and synthesis of a new series of hybrids of functionalised N1-[(1H-1,2,3-triazol-4-yl)methyl]quinazoline-2,4-dione with antiviral activity against Respiratory Syncytial Virus.

Adriano Camps, D. Schols, G. Andrei, 2022, Antiviral research.

Syntheses and anti-HIV and human cluster of differentiation 4 (CD4) down-modulating potencies of pyridine-fused cyclotriazadisulfonamide (CADA) compounds.

K. Vermeire, T. Bell, A. Intasiri, 2020, Bioorganic & medicinal chemistry.

A facile one pot multi component synthesis of alkyl 4-oxo-coumarinyl ethylidene hydrazono-thiazolidin-5-ylidene acetates and their antiviral activity

C. Kulkarni, K. Vermeire, R. R. Vedula, 2021, Journal of Molecular Structure.

Identification of novel Ebola virus inhibitors using biologically contained virus

P. Maes, A. Marchand, P. Chaltin, 2021, bioRxiv.

Early identification of availability issues for poorly water-soluble microbicide candidates in biorelevant media: a case study with saquinavir.

D. Schols, P. Augustijns, J. Brouwers, 2011, Antiviral research.

Identification of novel Ebola virus inhibitors using biologically contained virus.

P. Maes, A. Marchand, P. Chaltin, 2022, Antiviral research.

Specific Targeting of the F13L Protein by St-246 Affects Orthopoxvirus Production Differently

E. Vanstreels, A. Garcel, R. Jordan, 2008, Antiviral therapy.

Mannose-Specific Plant Lectins from the Amaryllidaceae Family Qualify as Efficient Microbicides for Prevention of Human Immunodeficiency Virus Infection

E. De Clercq, J. Balzarini, D. Schols, 2004, Antimicrobial Agents and Chemotherapy.

Sensitivity of human immunodeficiency virus to bicyclam derivatives is influenced by the three-dimensional structure of gp120

E. De Clercq, J. Anné, K. De Vreese, 1997, Antimicrobial agents and chemotherapy.

Microvirin, a Novel α(1,2)-Mannose-specific Lectin Isolated from Microcystis aeruginosa, Has Anti-HIV-1 Activity Comparable with That of Cyanovirin-N but a Much Higher Safety Profile*

E. Dittmann, J. Balzarini, D. Schols, 2010, The Journal of Biological Chemistry.

The candidate sulfonated microbicide, PRO 2000, has potential multiple mechanisms of action against HIV-1.

D. Schols, A. Profy, D. Huskens, 2009, Antiviral research.

Immunomodulatory properties of interferon-gamma. An update.

A. Billiau, H. Heremans, K. Vermeire, 1998, Annals of the New York Academy of Sciences.

Chemokine receptor antagonists as HIV entry inhibitors

E. Clercq, D. Schols, G. Bridger, 2004 .

A Proteomic Study on the Membrane Protein Fraction of T Cells Confirms High Substrate Selectivity for the ER Translocation Inhibitor Cyclotriazadisulfonamide

E. Hartmann, E. Krause, D. Schols, 2021, Molecular & cellular proteomics : MCP.

Safety concerns for the potential use of cyanovirin-N as a microbicidal anti-HIV agent.

J. Balzarini, D. Schols, D. Huskens, 2008, The international journal of biochemistry & cell biology.

Inhibitors of protein translocation across membranes of the secretory pathway: novel antimicrobial and anticancer agents

K. Vermeire, Victor Van Puyenbroeck, 2018, Cellular and Molecular Life Sciences.

Signal Peptide-Binding Drug as a Selective Inhibitor of Co-Translational Protein Translocation

E. Hartmann, K. Kalies, M. Marsh, 2014, PLoS biology.

Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12.

K. Van Laethem, J. Balzarini, D. Schols, 2007, Virology.

Specific CD4 down‐modulating compounds with potent anti‐HIV activity

D. Schols, K. Vermeire, 2003, Journal of leukocyte biology.

Sugar-Binding Proteins Potently Inhibit Dendritic Cell Human Immunodeficiency Virus Type 1 (HIV-1) Infection and Dendritic-Cell-Directed HIV-1 Transfer

J. Balzarini, D. Schols, S. Turville, 2005, Journal of Virology.

Inhibitors of the Sec61 Complex and Novel High Throughput Screening Strategies to Target the Protein Translocation Pathway

R. Schülein, K. Vermeire, Eva Pauwels, 2021, International journal of molecular sciences.

CXCR4‐targeting nanobodies differentially inhibit CXCR4 function and HIV entry

C. de Graaf, T. Handel, M. Smit, 2018, Biochemical pharmacology.

AMD3100, a Potent and Specific Antagonist of the Stromal Cell-Derived Factor-1 Chemokine Receptor CXCR4, Inhibits Autoimmune Joint Inflammation in IFN-γ Receptor-Deficient Mice1

Dominique Schols, E. De Clercq, A. Billiau, 2001, The Journal of Immunology.

Tuning Side Arm Electronics in Unsymmetrical Cyclotriazadisulfonamide (CADA) Endoplasmic Reticulum (ER) Translocation Inhibitors to Improve their Human Cluster of Differentiation 4 (CD4) Receptor Down-Modulating Potencies.

Nicholas C. Pflug, D. Schols, K. Vermeire, 2016, Journal of medicinal chemistry.

Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs).

E. Dittmann, M. Swanson, D. Markovitz, 2011, Antiviral research.

The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication

E. De Clercq, J. Anné, G. Werner, 1996, Journal of virology.

Inhibition of Human Immunodeficiency Virus Replication by a Dual CCR 5 / CXCR 4 Antagonist

Erik De Clercq, Dominique Schols, T. Schwartz, 2004 .

Mutations at the CXCR4 interaction sites for AMD3100 influence anti‐CXCR4 antibody binding and HIV‐1 entry

Dominique Schols, E. De Clercq, T. Schwartz, 2003, FEBS letters.

Preprotein signature for full susceptibility to the co‐translational translocation inhibitor cyclotriazadisulfonamide

E. Hartmann, K. Kalies, D. Schols, 2020, Traffic.

Structural insights into TRAP association with ribosome-Sec61 complex and translocon inhibition by a CADA derivative

E. Hartmann, Adriano Camps, P. Maes, 2023, Science advances.

Use of a sequential high throughput screening assay to identify novel inhibitors of the eukaryotic SRP-Sec61 targeting/translocation pathway

P. Scheerer, R. Schülein, G. Kleinau, 2018, PloS one.

Synthesis and structure-activity relationship studies of CD4 down-modulating cyclotriazadisulfonamide (CADA) analogues.

M. Drew, V. Catalano, D. Schols, 2006, Journal of medicinal chemistry.

Advancing Marburg virus antiviral screening: Optimization of a novel T7 polymerase-independent minigenome system.

P. Maes, K. Vermeire, J. Stroobants, 2020, Antiviral research.

Labyrinthopeptin A1 inhibits dengue and Zika virus infection by interfering with the viral phospholipid membrane.

D. Schols, S. Noppen, R. Süssmuth, 2021, Virology.

Novel Polymyxin-Inspired Peptidomimetics Targeting the SARS-CoV-2 Spike:hACE2 Interface

L. Naesens, S. Noppen, A. Stevaert, 2023, International journal of molecular sciences.

Intracellular flow cytometry complements RT-qPCR detection of circulating SARS-CoV-2 variants of concern

Adriano Camps, P. Maes, K. Vermeire, 2022, bioRxiv.

Visualising SARS-CoV-2 infection of the lung in deceased COVID-19 patients

P. Mombaerts, Mona Khan, E. Wauters, 2023, eBioMedicine.

A Multimodal Imaging-Supported Down Syndrome Mouse Model of RSV Infection

P. E. Van den Steen, J. Vanoirbeek, G. Vande Velde, 2023, Viruses.

A Proteomic Survey Indicates Sortilin as a Secondary Substrate of the ER Translocation Inhibitor Cyclotriazadisulfonamide (CADA)*

D. Schols, K. Vermeire, T. Bell, 2016, Molecular & Cellular Proteomics.

Synthesis and evaluation of 3-alkynyl-5-aryl-7-aza-indoles as broad-spectrum antiviral agents

Adriano Camps, J. Neyts, D. Schols, 2022, Frontiers in Chemistry.

Human Immunodeficiency Virus Type 1 Escape from Cyclotriazadisulfonamide-Induced CD4-Targeted Entry Inhibition Is Associated with Increased Neutralizing Antibody Susceptibility

K. Van Laethem, D. Schols, K. Vermeire, 2009, Journal of Virology.

Inhibitors of HIV infection via the cellular CD4 receptor.

D. Schols, K. Vermeire, T. Bell, 2006, Current medicinal chemistry.

CADA, a potential anti-HIV microbicide that specifically targets the cellular CD4 receptor.

G. Vanham, D. Schols, P. Augustijns, 2008, Current HIV research.

Cyclotriazadisulfonamides: promising new CD4-targeted anti-HIV drugs.

D. Schols, K. Vermeire, 2005, The Journal of antimicrobial chemotherapy.

Profile of Resistance of Human Immunodeficiency Virus to Mannose-Specific Plant Lectins

E. De Clercq, A. Vandamme, K. Van Laethem, 2004, Journal of Virology.

Improving potencies and properties of CD4 down-modulating CADA analogs

D. Schols, K. Vermeire, T. Bell, 2012, Expert opinion on drug discovery.

CD4 down-modulating compounds with potent anti-HIV activity.

D. Schols, K. Vermeire, T. Bell, 2004, Current pharmaceutical design.

Synthesis and Structure−Activity Relationship Studies of CD4 Down-Modulating Cyclotriazadisulfonamide (CADA) Analogues

M. Drew, V. Catalano, D. Schols, 2006 .

Synthesis of CADA Analog Prodrugs Designed as Novel Down-modulators of the CD4 Receptor

D. Schols, K. Vermeire, E. Scarbrough, 2009 .

Synthesis of Novel CADA Analog Prodrugs Designed as Down-Modulators of the CD4 Receptor

D. Schols, K. Vermeire, E. Scarbrough, 2010 .

Development and optimization of a novel T7 polymerase-independent Marburg virus minigenome system

P. Maes, K. Vermeire, J. Stroobants, 2020, bioRxiv.

The endoplasmic reticulum (ER): a crucial cellular hub in flavivirus infection and potential target site for antiviral interventions

K. Vermeire, Marijke Verhaegen, 2024, npj Viruses.